As the team lead by surgeon Stephen Chagares prepared a protocol for robotically-assisted mastectomy, the Institutional Review Board at Monmouth Medical Center provided guidance “every step of the way,” said Nicholas Fotopoulos, a research coordinator and an undergraduate at Princeton University in his sophomore year.
Our investigative story this week is an outgrowth of a correction.
Using a da Vinci robot for breast cancer surgery? Is it safe? Effective?
After 45 years of covering oncology, we stopped and asked our readers: who are you?
Last week, I discussed events resulting in the Chernobyl NPF accident, including unique aspects of the reactor-design which contributed to the accident, and which resulted in release of radiation to the environment. I also discussed the initial Soviet response. Next, I focus on the immediate medical consequences and the response of Soviet government to medical interventions.
As a physician-scientist, I have spent my career advancing research in women's health. I was a part of the planning effort to design and launch TMIST—the Tomosynthesis Mammographic Imaging Screening Trial.
Two weeks ago, HBO began screening a five-part series on Monday nights on the Chernobyl nuclear power facility (NPF) accident, which occurred more than 30 years ago on April 26, 1986.
When NCI renewed the Comprehensive Cancer Center designation for Rutgers Cancer Institute of New Jersey, it also acknowledged that the institution's catchment area now covers the entire state of New Jersey, having expanded from roughly three counties around its home location of New Brunswick.
Over the past decade there has been much consternation about overdiagnosis, the detection of cancers that would not have been diagnosed without screening.
Overdiagnosis is defined as the diagnosis of an asymptomatic cancer that would not have become clinically evident during the person's lifetime in the absence of screening or similar activities, such as diagnostic imaging tests that reveal “incidentalomas.”
